Welcome to Francis Academic Press

Academic Journal of Medicine & Health Sciences, 2023, 4(4); doi: 10.25236/AJMHS.2023.040404.

Advances in Research Related to Cognitive Impairment in Maintenance Hemodialysis Patients


Hezhou Cai, Liqun Chen

Corresponding Author:
Liqun Chen

Department of Nephrology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, China


Cognitive impairment is much more prevalent in patients with end-stage renal disease than in the general population. The mechanism of cognitive impairment is unclear, and it is currently believed that in addition to uremic toxin damage, followed by chronic inflammatory factors and dialysis complications influence, vascular problems, and sleep disturbances are also key. Cognitive impairment can cause prolonged hospitalization and decreased quality of daily life, and in severe cases affect patient survival. Early identification, assessment, intervention, and treatment of cognitive impairment can be beneficial to patients. This article describes the current risk factors, assessment options, and treatment modalities related to cognitive impairment in maintenance hemodialysis patients.


maintenance hemodialysis, cognitive impairment, risk factors, treatment

Cite This Paper

Hezhou Cai, Liqun Chen. Advances in Research Related to Cognitive Impairment in Maintenance Hemodialysis Patients. Academic Journal of Medicine & Health Sciences (2023) Vol. 4, Issue 4: 20-25. https://doi.org/10.25236/AJMHS.2023.040404.


[1] Sanford AM. Mild Cognitive Impairment. clin Geriatr Med. 2017;33(3):325-337.

[2] Palta P, Carlson MC, Crum RM, et al. Diabetes and cognitive decline in older adults: the ginkgo evaluation of memory study. J Gerontol: Series A 2018; 73(1):123e30.

[3] Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey [published correction appears in Lancet. 2012 Aug 18; 380(9842):650]. Lancet. 2012; 379(9818): 815-822.

[4] Drew DA, Weiner DE, Tighiouart H, et al: Cognitive decline and its risk factors in prevalent hemodialysis patients. Am J Kidney Dis, 2017; 69: 780-87

[5] van Zwieten A, Wong G, Ruospo M, et al. Associations of Cognitive Function and Education Level With All-Cause Mortality in Adults on Hemodialysis: Findings From the COGNITIVE-HD Study[J]. Am J Kidney Dis, 2019, 74(4):452-462.

[6] Angermann S, Schier J, Baumann M, et al. Cognitive Impairment is Associated with Mortality in Hemodialysis Patients. J Alzheimers Dis. 2018; 66(4): 1529-1537.

[7] Jiang L, Kong H, Zhang J, et al. Analysis of cognitive function changes and related influencing factors in young and middle-aged patients on maintenance hemodialysis for end-stage renal disease[J]. Chinese Journal of Frontiers in Medicine (Electronic Edition), 2017, 9(02):150-153.

[8] Au B, Dale-McGrath S, Tierney MC. Sex differences in the prevalence and incidence of mild cognitive impairment: a meta-analysis. Ageing Res Rev. 2017 May; 35: 176-199.

[9] Momtaz YA, Haron SA, Hamid TA, et al. Body Mass Index (BMI) and Cognitive Functions in Later Life. Curr Alzheimer Res. 2018; 15(2):195-200.

[10] Craig L, Hoo Z, Yan T, et al. Prevalence of dementia in ischaemic or mixed stroke populations: systematic review and meta-analysis. j Neurol Neurosurg Psychiatry.(2021) 73:1157-66.

[11] Nedergaard M, Goldman SA. Glymphatic failure as a final common pathway to dementia. Science. 2020 Oct 2;370(6512):50-56. 

[12] Eloot S, Holvoet E, Dequidt C, et al. The complexity of sleep disorders in dialysis patients. Clin Kidney J.(2021) 14:2029-36.

[13] Zhao Y, Zhang Y, Yang Z, et al. Sleep Disorders and Cognitive Impairment in Peritoneal Dialysis: A Multicenter Prospective Cohort Study. Kidney Blood Press Res. 2019; 44(5):1115-1127.

[14] Maung SC, El Sara A, Chapman C, et al. Sleep disorders and chronic kidney disease. World J Nephrol. 2016 May 6; 5(3):224-32.

[15] The European Uremic Toxins (EUTox) Database. Available online at:  www.uremic-toxins.org (accessed August 28, 2021).

[16] Kurella Tamura M, Unruh ML, Nissenson AR, et al. Effect of more frequent hemodialysis on cognitive function in the frequent hemodialysis network trials. Am J Kidney Dis. (2013) 61:228- 37.

[17] Nongnuch A, Panorchan K, Davenport A. Brain-kidney crosstalk. crit Care. (2014) 18:225.

[18] Viggiano D, Wagner CA, Martino G, et al. Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol. (2020) 16:452-69.

[19] Lepping RJ, Montgomery RN, Sharma P, et al. Normalization of cerebral blood flow, neurochemicals, and white matter integrity after kidney transplantation. Am Soc Nephrol.(2021) 32:177-87.

[20] Guo Yidan, Tian Ru, Luo Yang. Clinical study on the correlation between serum homocysteine and cognitive impairment in elderly hemodialysis patients [J]. Tianjin Medicine, 2019,47(03):295-298.

[21] Kamat PK, Mallonee CJ, George AK, et al. Homocysteine, Alcoholism, and Its Potential Epigenetic Mechanism. Alcohol Clin Exp Res. 2016 Dec; 40(12): 2474-2481.

[22] Polinder-Bos HA, García DV, Kuipers J, et al, Krijnen WP, et al. Hemodialysis induces an acute decline in cerebral blood flow in elderly patients. j Am Soc Nephrol. (2018) 29:1317- 25.

[23] Findlay MD, Dawson J, Dickie DA, et al. Investigating the relationship between cerebral blood flow and cognitive function in hemodialysis patients. Am Soc Nephrol. (2019) 30:147- 58.

[24] Daulatzai MA. Cerebral hypoperfusion and glucose hypometabolism: key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease. Neurosci Res. 2017; 95(4):943-972.

[25] Eldehni MT, Odudu A, Mcintyre CW. Brain white matter microstructure in end-stage kidney disease, cognitive impairment, and circulatory stress. Hemodial Int. (2019) 23:356-65.

[26] Cannon JA, Moffiffiffitt P, Perez-Moreno AC, et al. Cognitive impairment and heart failure: systematic review and meta-analysis. Card Fail.( 2017) 23:464-75.

[27] Kim HB, Park B, Shim JY. Anemia in Association with Cognitive Impairment: a Systematic Review and Meta-Analysis. J Alzheimers Dis. 2019; 72(3):803- 814.

[28] Arnold R, Issar T, Krishnan AV, et al. Neurological complications in chronic kidney disease. jRSM Cardiovasc Dis. 2016 Nov 3;5:2048004016677687.

[29] Kurella Tamura M, Tam K, Vittinghoffff E,et al. Inflammatory markers and risk for cognitive decline in chronic kidney disease: the CRIC study. Kidney Int Reports. (2017) 2:192- 200.

[30] Watanabe K, Watanabe T, Nakayama M. Cerebro-renal interactions: impact of uremic toxins on cognitive function. Neurotoxicology. 2014; 44: 184- 193.

[31] Murray AM, Tupper DE, Knopman DS, et al. Cognitive impairment in hemodialysis patients is common. Neurology. (2006) 67:216-23.

[32] Nieuwenhuis-Mark RE. The death knoll for the MMSE: has it outlived its purpose? J Geriatr Psychiatry Neurol. 2010; 23(3): 151-157.

[33] O'Bryant SE, Humphreys JD, Smith GE, et al. Detecting dementia with the Mini-Mental State Examination in highly educated individuals. Arch Neurol. 2008; 65(7):963-967.

[34] Van Patten R, Britton K, Tremont G. Comparing the Mini-Mental State Examination and the modified Mini-Mental State Examination in the detection of mild cognitive impairment in older adults. Int Psychogeriatr. 2019 May; 31(5):693-701.

[35] Ciesielska N, Sokołowski R, Mazur E, et al. Is the Montreal Cognitive Assessment (MoCA) test better suited than the Mini-Mental State Examination (MMSE) in mild cognitive impairment (MCI) detection among people aged over 60? Meta-analysis. Psychiatr Pol. 2016 Oct 31; 50(5):1039-1052. English, Polish.

[36] Yoelin AB, Saunders NW. score Disparity between the MMSE and the SLUMS. am J Alzheimers Dis Other Demen. 2017 Aug; 32(5):282-288.

[37] Neumann D, Mau W, Wienke A, et al. Peritoneal dialysis is associated with better cognitive function than hemodialysis over a one-year course. Kidney Int. (2018) 93:375-89.

[38] Peng HM, Shi Y, Zhu XY, et al. Meta-analysis of the effects of different renal replacement therapy modalities on cognitive function in patients with end-stage renal disease[J]. China Blood Purification, 2019, 18(02):90-97.

[39] Hu Yanyi, Deng Hongmei, Long Hongying, et al. Analysis of factors associated with cognitive dysfunction in maintenance hemodialysis patients and prevention and treatment experience [J]. Chinese general medicine, 2015, 13(02):320-322.

[40] Ling C, Evans D, Zhang Y, et al. The effects of cognitive behavioral therapy on depression and quality of life in patients with maintenance hemodialysis: a systematic review. bmc Psychiatry.(2020) 20:369.

[41] Mehrotra R, Cukor D, Unruh M, et al. Comparative efficacy of therapies for treatment of depression for patients undergoing maintenance hemodialysis: a randomized clinical trial. Ann Intern Med. (2019) 170:369-79.

[42] Friedli K, Guirguis A, Almond M, et al. Sertraline versus placebo in patients with major depressive disorder undergoing hemodialysis: a randomized, controlled feasibility trial. clin J Am Soc Nephrol.(2017) 12:280-6.